The present invention relates generally to ingestible capsules and, more particularly, to a process for determining the location of an ingested capsule as it transitions between segments of the digestive tract.
Ingestible capsules are well-known in the prior art. Such capsules are generally small pill-like devices that can be ingested or swallowed by a patient. It is known that such capsules may include one or more sensors for determining physiological parameters of the gastrointestinal tract, such as sensors for detecting temperature, pH, pressure and the like.
A number of methods of determining location of an ingestible capsule are known in the prior art. For example, it is known that signal strength or signal triangulation may be used to attempt to determine the location of an ingested capsule. However, the use of an RF signal has a number of disadvantages, including that it generally requires multiple antennas, various tissues may impact the signal differently, and patient movement may skew the results. It is also known that accelerometers may be used to attempt to determine location, but such methods also have disadvantages, such as drift, non-linear progression and rotational inaccuracy.
It is also known that certain physiological parameters may be associated with regions of the gastrointestinal tract. For example, a 1988 article entitled “Measurement of Gastrointestinal pH Profiles in Normal Ambulant Human Subjects” discloses pH measurements recorded by a capsule passing through the gastrointestinal tract. While pH has been correlated with transitions from the stomach to the small bowel (gastric emptying) and from the distal small bowel to the colon (ileo-caecal transition), often there are not significant pH variations correlated with certain regions of the gastrointestinal tract, and patients with gastrointestinal maladies may have abnormal readings.
Thus, there is need for accurately determining when an ingestible capsule moves from one segment of the gastrointestinal tract to another.
With parenthetical reference to corresponding parts, portions or surfaces of the disclosed embodiment, merely for the purposes of illustration and not by way of limitation, the present invention provides an improved method for determining the movement of an ingestible capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract comprising the steps of providing an ingestible capsule (20) having a pH sensor (22) and a pressure sensor (23), ingesting the capsule, recording pressure measurements and pH measurements from the ingestible capsule as it moves through the gastrointestinal tract, deriving a pressure pattern as a function of time and the pressure measurements, monitoring for a variation in pH, and determining if there is an appreciable variation in the pressure pattern at such time period, whereby the capsule's location at a first position may be determined. The step of deriving a pressure pattern as a function of time and the pressure measurements may comprise the step of conditioning the recorded pressure measurements. The conditioning may comprise the step of normalizing the pressure measurements by applying a baseline compensation, and the baseline may be about 3 mmHg. The conditioning may comprise the steps of filtering out data points in the pressure measurements above an upper limit and filtering out data points in the pressure measurements below a lower limit, and the upper limit may be about 200 mmHg and the lower limit may be about 9 mmHg. The method may comprise the step of comparing such pH variation and such variation in frequency of contractions to a reference template. The method may comprise determining if there is an appreciable variation in motility index at such time period. The method may further comprise the steps of monitoring for a second variation in pH and determining if there is an appreciable variation in the frequency of contractions at such second time period, whereby the capsule's location at a second position may be determined. The method may comprise the step of determining transit time between the first position and the second position.
Accordingly, the general object is to provide a method for determining the movement of an ingestible capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract based on pressure and pH.
Another object is to provide a method for confirming the movement of a capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract based on pressure patterns.
Another object is to provide a method for determining the movement of an ingestible capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract based on frequency of contractions.
Another object is to provide a method for determining the movement of an ingestible capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract as a function of the area under a curve of pressure readings versus time.
Another object is to provide a method for determining the movement of an ingestible capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract as a function of the amplitude and/or frequency of pressure readings.
Another object is to provide a method for determining transit time of a capsule through one or more segments of the gastrointestinal tract.
These and other objects and advantages will become apparent from the foregoing and ongoing written specification, the drawings, and the claims.
At the outset, it should be clearly understood that like reference numerals are intended to identify the same structural elements, portions or surfaces consistently throughout the several drawing figures, as such elements, portions or surfaces may be further described or explained by the entire written specification, of which this detailed description is an integral part. Unless otherwise indicated, the drawings are intended to be read (e.g., cross-hatching, arrangement of parts, proportion, degree, etc.) together with the specification, and are to be considered a portion of the entire written description of this invention. As used in the following description, the terms “horizontal”, “vertical”, “left”, “right”, “up” and “down”, as well as adjectival and adverbial derivatives thereof (e.g., “horizontally”, “rightwardly”, “upwardly”, etc.), simply refer to the orientation of the illustrated structure as the particular drawing figure faces the reader. Similarly', the terms “inwardly” and “outwardly” generally refer to the orientation of a surface relative to its axis of elongation, or axis of rotation, as appropriate.
A method is provided for determining the movement of an ingestible capsule from a first segment of the gastrointestinal tract to a second segment of the gastrointestinal tract as a function of pressure readings and pH readings taken by the ingested capsule.
A capsule 20 is ingested by a subject and readings from sensors on the capsule are taken as the capsule passes through the gastrointestinal tract of the subject. Data from the pressure sensor and pH sensor are collected and analyzed by comparison to a reference template and/or to each other, to determine the location of the capsule. In a first embodiment, variations in pH and motility index patterns are used to mark the transition of the ingested capsule from the distal ileum to the caecum. Pressure patterns are used to confirm whether or not a variation in pH, as compared to a reference template, denotes a transition from the distal small bowel or distal ileum to the right colon or caecum. Thus, pH and pressure patterns are compared to reference data and used to determine an ingested capsule's passage through the ileo-caecal junction. In a second embodiment, variations in pH and motility index patterns are used to mark the transition of the ingested capsule from the stomach to the small bowel.
As shown in
Capsule 20 includes a pressure sensor assembly 23 comprising a flexible sleeve 26 affixed to the shell of the capsule and defining a chamber 28 between the shell and the sleeve. A pressure sensor 29 is operatively arranged to sense pressure within chamber 28 and communicates with the chamber through a fluid port 30 at one end of the shell of the capsule. As shown, the pressure sleeve 26 of capsule 20 extends from a point below the middle of the capsule up over the top end of the capsule.
On the opposite end of capsule 20 to pressure sensor 23 is pH sensor 22. In the preferred embodiment, pH sensor 22 is a conventional ISFET type pH sensor. ISFET stands for ion-selective field effect transistor and the sensor is derived from MOSFET technology (metal oxide screen field effect transistor). A current between a source and a drain is controlled by a gate voltage. The gate is composed of a special chemical layer which is sensitive to free hydrogen ions (pH). Versions of this layer have been developed using aluminum oxide, silicon nitride and titanium oxide. Free hydrogen ions influence the voltage between the gate and the source. The effect on the drain current is based solely on electrostatic effects, so the hydrogen ions do not need to migrate through the pH sensitive layer. This allows equilibrium, and thus pH measurement, to be achieved in a matter of seconds. The sensor is an entirely solid state sensor, unlike glass bulb sensors which require a bulb filled with buffer solution. Only the gate surface is exposed to the sample.
In the preferred embodiment, the capsule transmits sensed data at about 434 MHz and measures 26.8 mm long by 11.7 mm in diameter. A portable data receiver worn by the subject receives and stores data transmitted by the capsule. Software performs data analysis and presents a graphical data display of pH, pressure and temperature readings for analysis. After activation and ingestion, the capsule senses and transmits data for at least 120 hours after activation. The pH, pressure and temperature data are transmitted from within the GI tract to the data receiver. In the preferred embodiment, the range and accuracy of the sensors are generally 0.05 to 9.0 pH units with an accuracy of ±0.5 pH units, 0 to 350 mmHg with an accuracy of 5 mmHg, or 10% above 100 mmHg, and 25° to 49° C. with an accuracy of ±1° C. The data receiver contains rechargeable batteries and when seated in a docking station allows for battery charging and data download. Data is downloaded from the data receiver through the docking station via USB connection to a Windows PC compatible laptop.
The pH readings from the ingested capsule are plotted against time, as shown in
However, not only is a variation in pH patterns used to determine that the capsule is at the junction between the stomach and small bowel or at the ileo-caecal junction, but an associated change in pressure pattern is also employed. In the preferred embodiment, pressure patterns derived from pressure measurements taken by the capsule as it passes through the gastrointestinal tract are used. In the preferred embodiment, the pressure data from the subject is conditioned to distinguish real contraction data from artifacts or “noise” within the data set, as well as to discount physiologically improbable values. In the preferred embodiment, both concerns are addressed as part of a process which inspects each data value in the pressure measurement data set provided by the capsule. Because the conditioning utilizes constant minimum and maximum threshold values to determine and eliminate data spikes and artifacts, the input pressure data is baseline compensated. As mentioned above, the pressure data is then conditioned by filtering out those sets of data points or contractions whose peaks are above a predetermined threshold or limit. In the preferred embodiment, this threshold is about 200 mmHg. In addition, those contraction patterns whose peaks are less than a predetermined threshold or limit are also filtered out. In the preferred embodiment, this minimum threshold is about 9 mmHg. Thus, in the preferred embodiment the process considers a set of baseline compensated pressure measurements and begins evaluating each value in linear sequence from beginning to end. If a point is found to exceed the defined maximum, then the high value or spike is removed with its associated ascending and descending artifact values by traversing the data set both behind and ahead of the detected spike and zeroing the spike and any associated values, until either its termination or a new contraction is detected. The determination that an artifact has terminated is defined as any data point below a minimum pressure value. Contrarily, finding the next contraction from the high value is based on the detection of three consecutive ascending values, which is interpreted as an ascent in pressure, indicating the edge of a different contraction. Thus, in determining, for example, the area under the curve for a given time interval, a pressure point is included in the calculation only if its value is greater than or equal to the sum of the baseline pressure and the minimum threshold and is below the sum of the baseline pressure and the maximum threshold.
Average pressure readings from the capsule plotted against transit time are shown in
As shown in
By basing location on both pH and pressure patterns, one can more accurately determine the movement of ingested capsule 20 from one segment of the gastrointestinal tract to a second segment of the gastrointestinal tract of a subject. In comparing patterns from a subject with the reference templates for both pH and pressure, if there is a correlation between a variation in pH B and a variation in frequency of contractions D and/or motility index F, then a determination of the capsule's location may be more accurate. Without this correlation, the capsule being located at or near the ileo-caecal junction is less certain.
The patterns indicate that the intraluminal environment of the gastrointestinal tract as it transitions from the small intestine into the colon changes. The caecum, as compared to the distal ileum, is a less contractile reservoir where colonic bacteria cause an acidic change in pH. Thus, in the preferred embodiment, capsule 20 is ingested by the subject and pH readings and pressure readings are taken and compared as indicated above. Certain pH reference values are known in the prior art, as shown in
Readings from a subject may be compared to the reference templates to determine location. Thus, a change in pH and a change in either frequency of contractions or motility index that correlates with the variations in the template may be used to determine location. In the preferred embodiment, the combined change in pH and motility index is used to mark the transition between the distal ileum and the caecum. By using patterns based on both pH and pressure, location is more accurate because changes in pH based on bacterial overgrowth or malignancies in the gastrointestinal tract are not assumed to be a transition from one segment to a second segment if they are not accompanied by a corresponding variation in the frequency of contractions or motility index.
With the determination that the capsule has passed from the stomach to the small bowel and then through the ileo-caecal junction, transit time through the small bowel is ascertained. Transit time through the colon can then be determined as well. This is useful in a number of clinical applications.
The present invention contemplates that many changes and modifications may be made. Therefore, while the presently-preferred form of the improved method has been shown and described, and a number of alternatives discussed, persons skilled in this art will readily appreciate that various additional changes and modifications may be made without departing from the spirit of the invention, as defined and differentiated by the following claims.
This application is a continuation of U.S. patent application Ser. No. 11/899,544, filed Sep. 6, 2007, which claims the benefit of U.S. Provisional Patent Application No. 60/843,038, filed Sep. 8, 2006, and U.S. Provisional Patent Application No. 60/930,451, filed May 16, 2007. The entire content of these applications are incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
60843038 | Sep 2006 | US | |
60930451 | May 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11899544 | Sep 2007 | US |
Child | 13326045 | US |